Linezolid Plus Standard of Care

NCT06958835 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

606

Enrollment

OTHER

Sponsor class

Conditions

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

Interventions

DRUG: Linezolid 600 mg
DRUG: Placebo

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]